Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study

scientific article published on 2 October 2017

Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1092049275
P356DOI10.1186/S12933-017-0606-7
P8608Fatcat IDrelease_4xvq2hbybzh3reoiry6ezinhja
P932PMC publication ID5625702
P698PubMed publication ID28969633

P2093author name stringAtsushi Hirayama
Shigemasa Tani
Tsukasa Yagi
Wataru Atsumi
Kenji Kawauchi
Rei Matsuo
P2860cites workCommon medications used by patients with type 2 diabetes mellitus: what are their effects on the lipid profile?Q26740253
Triglycerides and cardiovascular disease: a scientific statement from the American Heart AssociationQ28235865
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statinsQ29547856
Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Québec Cardiovascular StudyQ30979271
Is ischemia the only factor predicting cardiovascular outcomes in all diabetes mellitus patients?Q33582307
Triglycerides and small dense LDL: the twin Achilles heels of the Friedewald formulaQ34270559
Effect of fenugreek on hyperglycaemia and hyperlipidemia in diabetes and prediabetes: A meta-analysisQ34536586
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 DiabetesQ34673134
Measurement of small dense low-density lipoprotein particlesQ36154957
Clinical importance and therapeutic modulation of small dense low-density lipoprotein particlesQ36675450
Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study.Q37119482
Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studiesQ37172727
Changes in triglycerides and high-density lipoprotein cholesterol may precede peripheral insulin resistance, with 2-h insulin partially mediating this unidirectional relationship: a prospective cohort studyQ37394438
Effects of rosuvastatin versus atorvastatin on small dense low-density lipoprotein: a meta-analysis of randomized trialsQ38104228
Postprandial hypertriglyceridemia as a coronary risk factorQ38186473
Revised equations for estimated GFR from serum creatinine in JapanQ39513402
Low-density lipoprotein cholesterol to apolipoprotein B ratio is independently associated with metabolic syndrome in Korean men.Q39784759
Relationship of the triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio to the remainder of the lipid profile: The Very Large Database of Lipids-4 (VLDL-4) studyQ40671676
Usefulness of the LDL-C/apoB ratio in the overall evaluation of atherogenicity of lipid profileQ40680512
Diabetes and cardiovascular disease. The Framingham studyQ41509493
Predictive value of serum apolipoprotein B/LDL-cholesterol ratio in cardiometabolic risk: Population-based cohort studyQ42917836
Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle sizeQ43683403
Assessment of LDL Particle Size by Triglyceride/HDL-Cholesterol Ratio in Non-diabetic,Healthy Subjects without Prominent HyperlipidemiaQ44621125
Effect of dipeptidyl peptidase-4 inhibitor, vildagliptin on plasminogen activator inhibitor-1 in patients with diabetes mellitus.Q51308633
Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractionsQ73462749
Lowering the triglyceride/high-density lipoprotein cholesterol ratio is associated with the beneficial impact of pioglitazone on progression of coronary atherosclerosis in diabetic patients: insights from the PERISCOPE (Pioglitazone Effect on RegresQ83144004
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectlipoproteinQ28350
triglycerideQ186319
coronary artery diseaseQ844935
type 2 diabetesQ3025883
P304page(s)123
P577publication date2017-10-02
P1433published inCardiovascular DiabetologyQ2468083
P1476titleRelation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study
P478volume16

Reverse relations

cites work (P2860)
Q54996163Cardiovascular disease risk factor responses to a type 2 diabetes care model including nutritional ketosis induced by sustained carbohydrate restriction at 1 year: an open label, non-randomized, controlled study.
Q90364685Could remnant-like particle cholesterol become a risk factor in diabetic menopausal women with coronary artery disease? A cross-sectional study of single academic center in China
Q91757726Elevated triglycerides rather than other lipid parameters are associated with increased urinary albumin to creatinine ratio in the general population of China: a report from the REACTION study
Q90698756Impact of free fatty acids on prognosis in coronary artery disease patients under different glucose metabolism status
Q64897581Investigation into Lipid Management in Acute Coronary Syndrome Patients from the EXPLORE-J Study.
Q61443208Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study
Q64112606Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies

Search more.